- Home
- IMRX vs SEV Comparison
IMRX vs SEV Comparison
Compare IMRX & SEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- SEV
- Stock Information
- Founded
- IMRX 2008
- SEV 2019
- Country
- IMRX United States
- SEV United States
- Employees
- IMRX N/A
- SEV N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- SEV Auto Manufacturing
- Sector
- IMRX Health Care
- SEV Industrials
- Exchange
- IMRX Nasdaq
- SEV Nasdaq
- Market Cap
- IMRX 232.9M
- SEV 189.2M
- IPO Year
- IMRX 2021
- SEV N/A
- Fundamental
- Price
- IMRX $6.87
- SEV $7.55
- Analyst Decision
- IMRX Strong Buy
- SEV
- Analyst Count
- IMRX 5
- SEV 0
- Target Price
- IMRX $17.20
- SEV N/A
- AVG Volume (30 Days)
- IMRX 1.4M
- SEV 1.1M
- Earning Date
- IMRX 11-10-2025
- SEV 01-01-0001
- Dividend Yield
- IMRX N/A
- SEV N/A
- EPS Growth
- IMRX N/A
- SEV N/A
- EPS
- IMRX N/A
- SEV N/A
- Revenue
- IMRX N/A
- SEV N/A
- Revenue This Year
- IMRX N/A
- SEV N/A
- Revenue Next Year
- IMRX N/A
- SEV N/A
- P/E Ratio
- IMRX N/A
- SEV N/A
- Revenue Growth
- IMRX N/A
- SEV N/A
- 52 Week Low
- IMRX $1.10
- SEV $3.55
- 52 Week High
- IMRX $10.08
- SEV $22.43
- Technical
- Relative Strength Index (RSI)
- IMRX 57.97
- SEV N/A
- Support Level
- IMRX $6.10
- SEV N/A
- Resistance Level
- IMRX $5.92
- SEV N/A
- Average True Range (ATR)
- IMRX 0.48
- SEV 0.00
- MACD
- IMRX 0.09
- SEV 0.00
- Stochastic Oscillator
- IMRX 90.11
- SEV 0.00
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.